Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Avibactam is a non-β-lactam β-lactamase inhibitor that has been approved in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and nosocomial pneumonia, including ventilator-associated pneumonia. In Europe, ceftazidime-avib...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Das, Shampa, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J., Newell, Paul, Melnick, David, Critchley, Ian A., Stone, Gregory G., Nichols, Wright W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2019
Konular:
Minireview
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437548/
https://ncbi.nlm.nih.gov/pubmed/30670413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02187-18
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller